ANG-700 series (Angiogene)
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug NameANG-700 series (Angiogene)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGray Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGray Cancer InstituteAngiogene Pharmaceuticals
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A